Synthesis of 4‐Arylpiperazine Derivatives of Moclobemide: Potential Antidepressants with a Dual Mode of Action

References

• Blier , P. 2003 . The pharmacology of putative early‐onset antidepressant strategies . Eur. Neuropsychopharmacol. , 13 : 57 – 66 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Pessoa‐Mahana , H. , Araya‐Maturana , R. , Saitz , B. C. and Pessoa‐Mahana , C. David . 2003 . A synthetic overview of new molecules with 5‐HT1A binding affinities . Minirev. Med. Chem. , 3 : 77 – 93 . [CSA]
   Web of Science ®Google Scholar
• Oficialdegui , A. M. , Martinez , J. , Perez , S. , Heras , B. , Irurzun , M. , Palop , J. A. , Tordera , R. , Lasheras , B. , del Río , J. and Monge , A. 2000 . Design, synthesis and biological evaluation of new 3‐[(4‐aryl)piperazin‐1‐yl]‐1‐arylpropane derivatives as potential antidepressants with a dual mode of action. Serotonin reuptake inhibition and 5‐HT1A receptor antagonism . Il Farmaco , 55 : 345 – 353 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMedGoogle Scholar
• Glennon , R. A. 2003 . Higher‐end serotonin receptors: 5‐HT5, 5‐HT6, and 5‐HT7 . J. Med. Chem. , 46 ( 14 ) : 2795 – 2812 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mattson , R. J. , Catt , J. D. , Sloan , C. P. , Gao , Q. , Carter , R. B. , Gentile , A. , Mahle , C. D. , Mattos , F. F. , McGvern , R. , VanderMaelen , C. P. and Yocca , F. D. 2003 . Development of a presynaptic 5‐HT1A antagonist . Bioorg. Med. Chem. Lett. , 13 : 285 – 288 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Orús , L. , Sáinz , Y. , Pérez , S. , Oficialdegui , A. M. , Martínez , J. , Lasheras , B. , del Río , J. and Monge , A. 2002 . New 3‐[4‐(aryl) piperazin‐1‐yl] ‐1‐(benzo [b] thiophen‐2‐yl)propane derivatives with dual action at 5‐HT1A serotonin receptors and serotonin transporter as a new class of antidepressants . Pharmazie , 57 ( 6 ) : 355 – 357 .
   PubMed Web of Science ®Google Scholar
• Takeuchi , K. , Kohn , T. J. , Honigschmidt , N. A. , Rocco , P. V. , Spinazze , P. G. , Koch , D. J. , Nelson , D. L. , Wainscott , D. B. , Ahmad , L. J. , Shaw , J. , Threlkeld , P. G. and Wong , D. T. 2003 . Advances toward new antidepressants beyond SSRIs: 1‐aryloxy‐3‐piperidinylpropan‐2‐ols with dual 5‐HT1A receptor antagonism/SSRI activities. Part 1 . Bioorg. Med. Chem. Lett. , 13 : 1903 – 1905 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ghambarpour , A. , Hadizadeh , H. , Piri , F. and Rashidi‐Ranjbar , P. 1997 . Synthesis, conformational analysis and antidepressant activiiy of moclobemide new analogues . Pharm. Acta Helv. , 72 : 119 – 122 . [CSA] [CROSSREF]
   PubMedGoogle Scholar
• Pessoa‐Mahana , H. , Astudillo , C. I. and Araya‐Maturana , R. 2002 . Synthesis of N‐(morpholinomethyl)benzamides as moclobemide analogues . Synth. Commun. , 32 ( 9 ) : 1437 – 1445 . [CROSSREF]
   Web of Science ®Google Scholar
• López‐Rodríguez , M. L. , Ayala , D. , Benhamú , B. , Morcillo , M. J. and Viso , A. 2002 . Arylpiperazine derivatives acting at 5‐HT1A receptors . Curr. Med. Chem. , 9 ( 4 ) : 443 – 469 .
   PubMed Web of Science ®Google Scholar
• López‐Rodríguez , M. L. , Morcillo , M. J. , Fernández , E. , Benhamú , B. , Tejada , I. , Ayala , D. , Viso , A. , Olivella , M. , Pardo , L. , Delgado , M. , Manzanares , J. and Fuentes , J. A. 2003 . Design and synthesis of S‐(−)‐2[[4‐(napht‐l‐yl)piperazin‐1‐yl]‐methyl]‐1,4‐dioxoperhydropyrrolo[1,2‐a]pyrazine (CSP‐2503) using computational stimulation. A 5‐HT1A receptor agonist . Bioorg. Med. Chem. Lett. , 13 : 1429 – 1432 . [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar